RE: Transition to phase 2 of DHSC contract10 Jan 2021 15:03
29th Sept 2020
"...Novacyt has the capacity to meet the demand of both phases of this new contract, as well as to continue to build its sales across international markets..."
So, no problem meeting Phase1/phase 2 AND international demand.
16th November 2020... (48 days later)
the Company has significantly increased the manufacturing capability of IT-IS to manage the growing demand for its q16 and q32 instruments. From November 2020, the Company has scaled-up manufacturing capacity for instrument production more than five-fold, with further expansion planned, depending on continued demand.
So in the space of 48 days NCYT go from being able to cope with phase 1 AND 2, AND international demand, to having to increase production of Q16/32 by 5 times !!!!!